Catalyst Wire Dossier Catalyst Wire Dossier

Fluciclovine F18

fluciclovine F-18
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Fluciclovine F18, covering 2024-05-17 to 2024-05-17. Get the full timeline:

Most recent: Clinical Trial Update: Fluciclovine F18 or Ga68-PSMA PET/CT to Enhance Prostate Cancer Outcomes [Phase 2]

See pricing